Close Asset Management LTD Biogen Inc. Transaction History

Close Asset Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $6,243 - $8,829	-24 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $230,730 - $258,435	-750 Reduced 96.9%	24 $8,000
Q3 2017 Feb 13, 2018	BUY	$281.15 - $329.69 $6,747 - $7,912	24 Added 3.2%	774 $0
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $6,747 - $7,912	-24 Reduced 3.1%	750 $235,000
Q2 2017 Feb 13, 2018	BUY	N/A	24 Added 3.2%	774 $210,000
Q2 2017 Nov 14, 2017	SELL	N/A	-24 Reduced 3.1%	750 $0
Q1 2017 Feb 13, 2018	BUY	N/A	24 Added 3.2%	774 $212,000
Q1 2017 Nov 14, 2017	BUY	N/A	750	750 $205,000

1,036

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Close Asset Management LTD with notifications on news.